![David Deng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Deng
Corporate Officer/Principal presso Verinata Health, Inc.
Posizioni attive di David Deng
Società | Posizione | Inizio | Fine |
---|---|---|---|
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 11/08/2009 | - |
Direttore/Membro del Consiglio | 11/08/2009 | 11/08/2009 |
Storia della carriera di David Deng
Precedenti posizioni note di David Deng
Società | Posizione | Inizio | Fine |
---|---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Formazione di David Deng
McGill University | Doctorate Degree |
Shanghai Jiao Tong University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Canada | 2 |
Cina | 2 |
Posizioni
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Settori
Consumer Services | 3 |
Health Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Commercial Services |
Aziende private | 1 |
---|---|
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
- Borsa valori
- Insiders
- David Deng
- Esperienza